CClinicalTrials.gg
CompletedNCT00342108Updated Nov 3, 2010

Cortical Visual Impairment and Visual Attentiveness

An interventional study of cross-modal sensory stimulation in Cerebral Palsy and Cortical Visual Impairment, sponsored by Sheba Medical Center. Completed at 1 site in Israel. Open to participants aged 2 Years to 21 Years. Per ClinicalTrials.gov, last updated 2010-11-03.

Sponsored by Sheba Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
2 Years to 21 Years
Sex
All
01

Study summary

This study will investigate the effect of enhanced visual and cross-modal environments upon the visual attentiveness of multiply handicapped children diagnosed with Cerebral Palsy (CP) and Cortical Visual Impairment (CVI).

Research Hypothesis

  1. Adapted visual environments which present controlled auditory, tactile, proprioceptive or contrasting visual background stimulation will enhance the visual attentiveness to a given visual stimulus of children diagnosed with CP and CVI.
  2. Systematic, repetitive, visual stimulation over time, improves the visual attentiveness and/or visual-motor responses of CP-CVI children.
  3. The analysis of additional behavioral responses to visual stimuli is a critical component in evaluating the perceptual development of visual attention in CP-CVI children.

Use of Noldus: The Observer, an advanced objective computerized observation program, will enable precise detection of the neurobehavioral responses of the participants. Both overt and covert responses will be observed, analyzed and correlated to identify the level of attention of each participant.

02

Conditions studied

  • Cerebral Palsy
  • Cortical Visual Impairment
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's enrollment of 60 is above the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • two to twelve years of age
  • diagnosis of: CP, mental retardation (MR) and CVI (Control group participants without visual disability)

Exclusion criteria

Exclusion Criteria:

  • N/A
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    1

    Diagnosis: CP, moderate to severe MR and CVI

    Behavioral: cross-modal sensory stimulation

  • Experimental
    2

    Diagnosis: CP, Moderate to severe MR, no visual impairment

    Behavioral: cross-modal sensory stimulation

Interventions

  • Behavioralcross-modal sensory stimulation

    comparison of participant response to unimodal visual stimulation and to bimodal sensory stimulation

06

What researchers measure

Primary outcomes

  1. Eye Movements

    Time frame: within the testing session

Secondary outcomes

  1. Other behavioural responses

    Time frame: within the testing session

07

Study locations

1 site
  • Sheba_Medical_Center
    Ramat Gan, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 3, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00342108
Lead sponsor
Sheba Medical Center
First posted
Jun 21, 2006
Start date
Sep 2007
Primary completion
Jul 2009
Completion
Oct 2010
Last update
Nov 3, 2010

Study contacts

Amichai Brezner, MD
principal investigator · Dept. of Pediatric Rehabilitation Sheba Medical Center Israel

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion